CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia.

By S. Maude, D. Teachey, D. Porter, S. Grupp. Blood, 2015

663 citations recorded by the source corpus.

Subfields: Electrical and Electronic Engineering, Oncology

View Paper: https://www.semanticscholar.org/paper/2cafbe0bf15ebef5f31f34241a0d4d7cf0243baf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Shimabukuro-Vornhagen
2. M. V. von Bergwelt-Baildon
3. M. Subklewe
4. Philipp Gödel
5. H. Schlößer
6. M. Kochanek
7. H. Stemmler
8. M. Schlaak

Citations in the corpus

• Cytokine release syndrome (2018, result): “However, in a study of 30 B-ALL patients treated with CD19-CAR T cells (CTL019) 2 of 9 patients treated with immunosuppression eventually relapsed with 11 patients relapsing overall within a follow-up of 2 to 24 months [32].”